Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Fox

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Plos One|October 18, 2022
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trialTazio Vanni, Beatriz C Thomé, Erin Sparrow, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Nature Communications|November 25, 2017
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizationsWilton B Williams, Jinsong Zhang, Chuancang Jiang, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Cell|November 2, 2025
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Science Immunology|July 16, 2021
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Plos One|October 18, 2022
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trialTazio Vanni, Beatriz C Thomé, Erin Sparrow, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Nature Communications|November 25, 2017
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizationsWilton B Williams, Jinsong Zhang, Chuancang Jiang, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Cell|November 2, 2025
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Science Immunology|July 16, 2021
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Pageof 15